LDLorine Debande

Lorine Debande

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lorine Debande has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Human-targeted drugs extensively reshape regulatory networks controlling virulence and antibiotic resistance in Salmonella Typhimurium

    by Martin K. Amstalden, Roberto Olayo-Alarcón, Susanne Brenzinger, Lorine Debande, Annamaria Zannoni, Elisabetta Fiore, Abdelhakim Boudrioua, Azam Rashidian, Thales Kronenberger, Samuel Wagner, et al.

    Human-targeted drugs are increasingly recognized to affect bacterial physiology, yet their impact beyond growth inhibition, and the underlying molecular mechanisms, remain poorly understood. Here, we systematically mapped how chemically diverse host-associated compounds influence virulence and intrinsic antibiotic resistance in Salmonella enterica serovar Typhimurium. Using a high-throughput reporter approach, we quantified transcriptional response of 26 key stress promoters in Salmonella against 2,415 compounds, including FDA-approved drugs, food-derived molecules, and human metabolites. We found that non-antibiotic compounds induce transcriptional responses distinct from those elicited by antibiotics, uncovering a regulatory shift from general stress responses to compound-specific regulation driven by ligand-responsive MarR- and TetR-family regulators. In particular, more than 200 non-antibiotic drugs modulate virulence or intrinsic resistance pathways through the central regulators SlyA or RamR, respectively. By integrating our large-scale dataset with machine learning, we further defined chemical features associated with ramA transcriptional activation in Salmonella , and predicted ∼200 additional candidate inducers of intrinsic antibiotic resistance in this pathogen. Together, our results uncovered a large and previously unrecognized chemical landscape that reshapes bacterial stress responses through ligand-responsive regulatory mechanisms, with implications for how host-associated compounds influence pathogen virulence and antibiotic resistance. Highlights: Mapping the transcriptional response of key Salmonella stress pathways across a large chemical space shows that antibiotics and non-antibiotic compounds elicit distinct stress responses in Salmonella The activity of the virulence regulator SlyA is modulated by non-antibiotic compounds SlyA-inhibitors increase sensitivity to polymyxin B and decrease Salmonella virulence in cell culture Human-targeted drugs increase intrinsic antibiotic resistance via RamR-RamA in Salmonella Machine learning approach enables large-scale, out-of-sample prediction of human-targeted drugs inducing ramA expression in Salmonella


  • Open Access

    SigA forms amyloid fibrils that associate with the colicin ColE1 to support the antibacterial activity of Shigella sonnei before colonization

    by Ahmad Sabbah, Julie Maucotel, Béatrice Roche, Mathieu Erhardt, Lorine Debande, Charlotte E. Chong, Antoine Schramm, Jérémy Fraering, Johana Chicher, Eric Ennifar, et al.

    Shigella sonnei is an enteropathogen that causes bacillary dysentery. During the first step of its virulence cycle, it must outcompete the resident microbiota to establish its own niche. Here we report that SigA, the sole SPATE (Serine Protease Autotransporter of Enterobacteriaceae) family member in S. sonnei , plays an indirect but central role in this process. A genome-wide analysis showed that the SPATE family includes SigA, Pic, SepA, and Sat. We demonstrated that SigA self-assembles into amyloid fibrils (F-SigA) independently of its protease activity. F-SigA remains associated with the S. sonnei surface in vitro and in vivo . Purified F-SigA fibrils have a diameter of 17.7 ± 3.2 nm, and their amyloid organization was confirmed using specific markers and biochemical methods. F-SigA is secreted into the lumen in vivo and localizes to the surface of the colonic epithelium. We found that colicin E1 (ColE1) interacts with F-SigA amyloid fibrils, and that F-SigA–ColE1 complexes display antimicrobial activity that promotes S. sonnei competition with other bacteria. Because Pic, another Shigella SPATE, also forms amyloid fibrils, we anticipate that this virulence mechanism may be relevant across a wide range of Shigella strains and enterobacteria and may serve additional roles during the Shigella virulence cycle.

  • Contribution des SPATEs SigA et SepA dans la survie de Shigella dans le plasma

    by Lorine Debande

    Les Shigella sont les pathogènes responsables de la shigellose, caractérisée par de la fièvre, une diarrhée hémorragique et dans les cas les plus graves, une bactériémie. Ainsi, les Shigella sont exposées au sang mais les mécanismes qui permettent à ces bactéries de s’adapter et de survivre à l’exposition au plasma restent méconnus. Durant ma thèse, dans un modèle de shigellose chez le cobaye, j'ai confirmé l’induction d’hémorragies locales par Shigella et que les bactéries atteignaient les vaisseaux sanguins dans la muqueuse colique et se disséminaient ensuite dans la circulation sanguine, confirmant l'exposition de Shigella au plasma. Toutes les souches de Shigella testées survivaient à l'exposition au plasma in vitro. En utilisant des mutants, j’ai démontré que les Protéases à Sérine AutoTransportées des Entérobactéries sont essentielles à la dissémination de Shigella dans la muqueuse colique et dans la circulation sanguine et que ces protéases favorisaient la survie de Shigella dans le plasma en clivant le composant C3 du complément. J'ai ainsi montré que la capacité de Shigella à survivre à l'exposition au plasma est un facteur clé de sa virulence.

  • Open Access

    SPATEs promote the survival of Shigella to the plasma complement system upon local hemorrhage and bacteremia

    by Lorine Debande, Ahmad Sabbah, Lauriane Kuhn, Richard Patryk Ngondo, Julie Maucotel, Marina Valente-Barroso, Antonin C. André, Béatrice Roche, Matthieu Laborde, Maria-Victoria Cantalapiedra-Mateo, et al.

    Shigella spp. are the causative agents of shigellosis, which remains a leading cause of death in children under the age of 5. Symptoms of shigellosis include bloody diarrhea, associated to colon hemorrhage; in more severe cases , Shigella bacteremia is induced. These clinical features indicate that Shigella are exposed and survive exposure to plasma, locally and systemically, although this has not yet been studied at a molecular level. In this report, we confirmed in a guinea pig model of shigellosis that both S. flexneri 5a and S. sonnei induced local hemorrhages and we demonstrated that Shigella reached CD31+/CD34+ blood vessels located in the mucosa during the late stages of infection, and further disseminated in the bloodstream. These results confirmed the exposure of Shigella to plasma components during its virulence cycle. We demonstrated that all the tested Shigella strains survived plasma exposure in vitro, and we showed that Serine Protease Autotransporters of Enterobacteriaceae (SPATEs) contribute to Shigella dissemination within the colonic mucosa and in the bloodstream. We have confirmed that SPATEs are expressed and secreted in poorly oxygenated environments encountered by Shigella during late infection stages. We further demonstrated that SPATEs promoted Shigella survival in plasma, by cleaving complement component 3 (C3), thereby impairing the complement system activation. We have shown here that the ability of Shigella to survive plasma exposure is a key factor in its virulence, both within primary foci and systemically.


  • Open Access

    SPATEs promote the survival of Shigella to the plasma complement system upon local hemorrhage and bacteremia

    by Lorine Debande, Ahmad Sabbah, Laurianne Kuhn, Patryk Ngondo, Antonin C André, Béatrice Roche, Matthieu Laborde, Victoria Cantalapiedra-Mateo, Tamou Thahouly, Ana Milinski, et al.

    Shigella spp. are the causative agents of shigellosis, which remains a leading cause of death in children under the age of five. Shigellosis is characterized by fever and results in hemorrhagic diarrhea; in more severe cases, Shigella bacteremia has been reported. These clinical features strongly suggest that Shigella survive exposure to plasma, although this has not yet been studied at the molecular level. In this report, we confirmed in a guinea pig model of shigellosis that local hemorrhages were induced by S. flexneri 5a and S. sonnei , and we demonstrated that Shigella reached mucosal CD31+/CD34+ blood vessels during the late stages of infection and further disseminated in the bloodstream. These results confirmed the exposure of Shigella to plasma components within the hemorrhagic colonic mucosa and in the bloodstream. We demonstrated that all the tested Shigella strains survived plasma exposure in vitro , and we showed that Serine Protease Autotransporters of Enterobacteriaceae (SPATEs) are essential for Shigella dissemination within the colonic mucosa. We have confirmed that SPATEs are expressed and secreted in poorly oxygenated environments encountered by Shigella from hypoxic foci of infection to the bloodstream. We further demonstrated that SPATEs promoted Shigella survival in plasma, by cleaving complement component 3 (C3), thereby impairing complement system activation. We have shown here that the ability of Shigella to survive plasma exposure is a key factor in its virulence, both within primary foci and systemically. Significance Statement: In this study we aimed to better understand the significance of the ability of Shigella to survive plasma exposure, as we observed that non-pathogenic E. coli rapidly lysed upon exposure. Indeed, we reported that Shigella was already exposed to plasma components within the colonic mucosa, as we reported in a guinea pig model of shigellosis that hemorrhages were induced, that were associated with local diffusion of plasma components in the infected colonic mucosa. Shigella was obviously exposed to plasma during bacteremia. The ability of Shigella to survive in plasma has not been previously reported. Here we have shown, first, that Shigella was able to divide and grow in the presence of human plasma, and second, we found that SPATEs played a central role in this process by impairing with the activation of the complement system.


  • Open Access

    Escherichia coli killing by epidemiologically successful sublineages of Shigella sonnei is mediated by colicins

    by P. Malaka De Silva, Rebecca J. Bennett, Lauriane Kuhn, Patryk Ngondo, Lorine Debande, Elisabeth Njamkepo, Brian Ho, François-Xavier Weill, Benoît S. Marteyn, Claire Jenkins, et al.